[Translation] A single-center, open-label, randomized, two-dose, two-sequence, four-period, fully repeated crossover bioequivalence study of sacubitril-valsartan sodium tablets in Chinese healthy volunteers in the fasting and fed state
研究健康受试者空腹及餐后单次口服受试制剂沙库巴曲缬沙坦钠片(山东鲁抗医药集团赛特有限责任公司,规格:200mg,沙库巴曲/缬沙坦(97mg/103mg))与参比制剂沙库巴曲缬沙坦钠片(商品名:诺欣妥 ®,Novartis Pharma Schweiz AG,规格:200mg,沙库巴曲/缬沙坦(97mg/103mg))在吸收程度和速度方面是否存在差异,评价受试制剂和参比制剂在空腹及餐后状态下给药时的生物等效性,观察受试制剂和参比制剂在健康受试者中的安全性。
[Translation] To investigate whether there are differences in the extent and rate of absorption between the test preparation sacubitril-valsartan sodium tablets (Shandong Lukang Pharmaceutical Group Saite Co., Ltd., specification: 200 mg, sacubitril/valsartan (97 mg/103 mg)) and the reference preparation sacubitril-valsartan sodium tablets (trade name: Nusintuo ®, Novartis Pharma Schweiz AG, specification: 200 mg, sacubitril/valsartan (97 mg/103 mg)) after a single oral administration on an empty stomach or after a meal in healthy subjects, to evaluate the bioequivalence of the test preparation and the reference preparation when administered on an empty stomach or after a meal, and to observe the safety of the test preparation and the reference preparation in healthy subjects.